ArticleJournal of clinical and experimental hematopathology : JCEH2018
Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission.
Article in Journal of clinical and experimental hematopathology : JCEH, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Diagnostic challenges posed by the wide morphological and immunophenotypic spectrum of plasma cell neoplasms.Blood research · 2026Review
- Analysis of clinical characteristics, treatment response, and prognosis among 67 patients with anaplastic multiple myeloma.World journal of surgical oncology · 2025Article
- Anaplastic Multiple Myeloma With a Novel Proliferation of Pleomorphic Binuclear Plasma Cells.Cureus · 2024Article
- Article
- Cardiovascular Involvement of a CD138-Negative Anaplastic Myeloma: A Diagnostic Dilemma.Hematology reports · 2023Article
- Anaplastic multiple myeloma with MYC rearrangement.Leukemia research reports · 2022Article
- Article
- Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy.Annals of hematology · 2021Article
- Anaplastic morphology in IgD multiple myeloma.Hematology, transfusion and cell therapyArticle
- Anaplastic Multiple Myeloma: Case Series and Literature Review.Asploro journal of biomedical and clinical case reportsArticle
- Anaplastic plasma cell myeloma - A morphological dilemma.Hematology, transfusion and cell therapyArticle
- Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma.Journal of clinical and experimental hematopathology : JCEHArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.